FLAVONOÏDES VIATRIS CONSEIL 500 mg, film-coated tablet 120 tablets
Active ingredients: FRACTION FLAVONOÏQUE PURIFIÉE MICRONISÉE
Commercialized according to BDPM
Film-coated tablet120 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FLAVONOÏDES VIATRIS CONSEIL 500 mg comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 120 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 18 Jul 2024
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63469776CIP73020089CIP133400930200896Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FRACTION FLAVONOÏQUE PURIFIÉE MICRONISÉEcomprimé | 500 mg dont 450 mg de diosmine et 50 mg de falvonïdes exprimés en hespéridine · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.